PHARMACY

Kentucky’s leading Medicaid plan adds The Little Clinic to network

BY Michael Johnsen

LOUISVILLE, Ky. – Passport Health Plan has added The Little Clinic inside select Kroger stores around Kentucky to its growing network of accepted healthcare providers, effective Jan. 1, 2017, the companies announced Thursday.

“We are very excited to add The Little Clinic to our network of healthcare providers around the Commonwealth,” stated Mark Carter, CEO of Passport Health Plan. “Opening access to these additional services will allow our members to get the care and treatment that they need to live healthier lives.”

The Little Clinic locations are staffed with board-certified nurse practitioners authorized to diagnose, treat, and write prescriptions for many common illnesses such as bronchitis, sinus infections, seasonal allergies and the flu. The clinics also provide a wide selection of additional wellness services such as physicals, health screenings, tobacco cessation, and a number of vaccinations.

Passport Health Plan is a provider-sponsored, non-profit, community-based health plan administering Medicaid benefits to nearly 300,000 Kentuckians. Named the top Medicaid plan in Kentucky by the National Committee for Quality Assurance for 2015-16 and 2016-17, Passport has been contracted with the Commonwealth of Kentucky to administer Medicaid benefits since 1997.
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

FDA approves Teligent’s generic Clobex lotion

BY David Salazar
SILVER SPRING, Md. — The Food and Drug Administration has approved Teligent’s generic of Clobex (clobetasol propionate, 0.05%) lotion, the company announced Wednesday. The approval is the company’s sixth in its internally developed pipeline of generics. 
 
“Teligent now has two products which have been approved by the FDA in a first round review, which exceeds current industry average review time periods published by the FDA in October of 2016,” Teligent president and CEO Jason Grenfell-Gardner said. “This is our thirteenth product in our domestic portfolio, and our commercialization team expects to launch this product in the first quarter of 2017."
 
The drug has an addressable market size of approximately $19.5 million, according to QunitilesIMS data from October. 
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

QS/1 joins retailers, PBMs at MTM and Adherence Innovations Summit

BY DSN STAFF
CHICAGO — Strategic Solutions Network’s fourth annual MTM and Medication Adherence Innovations Summit brought some 70 healthcare professionals and industry leaders together recently to discuss how best to improve patient adherence.
 
Among the participants were representatives from such companies as Walmart, ExpressScripts and OutcomesMTM, a Cardinal Health company. Also participating was QS/1 market analyst senior manager Ed Vess, who offered input into pharmacy’s role in medication management and improving patient outcomes. 
 
“Pharmacists play a clear and vital role in adherence,” Vess said.  “We want to make sure QS/1 is looking out for the interests of community pharmacy during these discussions. Everyone involved in healthcare needs to have a voice in this important discussion. It’s imperative for everyone to share their input so the solutions incorporate everyone and have a positive impact on the patient’s outcomes.”
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES